Interview with Prof Reis-Filho on molecular pathology at the basis of personalised medicine
Prof Reis-Filho explores the latest high throughput technology results in molecular pathology to improve treatment for cancer patients.
Interview with Dr Angelo Di Leo on potential new promising approaches to attack the different subtypes of triple negative breast cancer
Dr Di Leo explains why triple negative breast cancer is a difficult heterogeneous disease and which are potential new promising approaches.
Interview with Prof Swanton on the challenges posed by intratumor heterogeneity
Prof Swanton offers a clear-cut picture of challeges and opportunities offered by improved knowledge of intratumor heterogeneity.